Oppenheimer & Co’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-32,043
| Closed | -$17.3K | – | 1568 |
|
|
2024
Q4 | $17.3K | Sell |
32,043
-4,232
| -12% | -$2.28K | ﹤0.01% | 1542 |
|
|
2024
Q3 | $34.5K | Sell |
36,275
-3,023
| -8% | -$2.87K | ﹤0.01% | 1490 |
|
|
2024
Q2 | $38.3K | Sell |
39,298
-4,534
| -10% | -$4.42K | ﹤0.01% | 1411 |
|
|
2024
Q1 | $69.3K | Sell |
43,832
-6,271
| -13% | -$9.91K | ﹤0.01% | 1402 |
|
|
2023
Q4 | $39.7K | Sell |
50,103
-18,068
| -27% | -$14.3K | ﹤0.01% | 1357 |
|
|
2023
Q3 | $53.2K | Hold |
68,171
| – | – | ﹤0.01% | 1340 |
|
|
2023
Q2 | $63.1K | Buy |
+68,171
| New | +$63.1K | ﹤0.01% | 1372 |
|
|
2020
Q4 | – | Sell |
-36,837
| Closed | -$294K | – | 1341 |
|
|
2020
Q3 | $294K | Buy |
+36,837
| New | +$294K | 0.01% | 989 |
|